Model Answer
0 min readIntroduction
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare, life-threatening severe cutaneous adverse reactions, most commonly triggered by medications. They are considered a spectrum of the same disease, with SJS affecting less than 10% of the body surface area (BSA), TEN affecting more than 30% BSA, and SJS/TEN overlap falling between these ranges. These conditions involve widespread epidermal detachment, leading to significant morbidity and mortality. Understanding the mortality rates associated with these conditions is crucial for appropriate clinical management and prognosis.
Understanding SJS and TEN
Both SJS and TEN are characterized by mucocutaneous involvement, fever, and a flu-like prodrome. The primary difference lies in the extent of epidermal detachment. The pathogenesis involves a delayed hypersensitivity reaction, often to a drug, leading to keratinocyte death and widespread blistering.
Factors Influencing Mortality
Several factors significantly impact the mortality rate in SJS and TEN:
- Extent of BSA Detachment: A larger percentage of BSA involvement directly correlates with increased mortality.
- Age: Older patients generally have higher mortality rates due to comorbidities and reduced physiological reserve.
- Comorbidities: Pre-existing conditions like renal failure, heart failure, and diabetes increase the risk of a fatal outcome.
- SCORTEN Score: The SCORTEN (Severity-of-Illness Score for Toxic Epidermal Necrolysis) is a validated scoring system that predicts mortality based on several clinical and laboratory parameters.
- Early Recognition and Management: Prompt diagnosis, discontinuation of the offending drug, and supportive care in a burn unit significantly improve outcomes.
Mortality Rates
The mortality rates for SJS and TEN vary considerably based on the factors mentioned above. Here's a breakdown:
| Condition | Mortality Rate | Notes |
|---|---|---|
| SJS | 1-5% | Lower end of the spectrum, generally less severe. |
| SJS/TEN Overlap | 5-12% | Intermediate severity. |
| TEN | 25-35% | Highest mortality rate, often requiring intensive care. |
SCORTEN Score and Mortality
The SCORTEN score provides a more refined risk assessment. A score of 0-3 indicates a low risk of mortality (less than 3%), 4-5 indicates an intermediate risk (3-10%), and 6 or higher indicates a high risk (greater than 30%).
Common Causative Agents
Drugs are the most common cause of SJS/TEN. Frequently implicated medications include:
- Allopurinol
- Antibiotics (Sulfonamides, Penicillins)
- Anticonvulsants (Phenytoin, Carbamazepine)
- NSAIDs
- Nevirapine
Infections, particularly Mycoplasma pneumoniae, can also trigger SJS, especially in children.
Conclusion
SJS and TEN are severe, potentially fatal dermatological emergencies. Mortality rates vary significantly depending on the extent of epidermal detachment, patient age, comorbidities, and the promptness of treatment. Utilizing scoring systems like SCORTEN aids in risk stratification and guides clinical management. Early recognition, discontinuation of the offending agent, and supportive care in specialized burn units are crucial for improving patient outcomes and reducing mortality. Continued research into the pathogenesis and optimal treatment strategies remains essential.
Answer Length
This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.